FIELD: medicine.
SUBSTANCE: invention relates to an injectable pharmaceutical composition for the treatment of acute hepatitis in animals. Injectable pharmaceutical composition based on methyluracil (dioxomethyltetrahydropyrimidine) contains methylpyrrolidone, succinic acid and water in the following ratio, wt.%: methyluracil — 0.5–2.05; methylpyrrolidone — 9.0–70.0; succinic acid — 0.4–2.0; distilled water — the rest.
EFFECT: above described injectable pharmaceutical composition has a pronounced stimulating property and therapeutic efficacy.
1 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| HEPATOPROTECTIVE INJECTION PHARMACEUTICAL COMPOSITION ON THE BASIS OF SILIMARINE AND NANOPARTICLES OF SELENIUM | 2017 |
|
RU2645092C1 |
| PHARMACOLOGICAL COMPOSITION FOR TREATING PROCTOLOGIC DISEASES (EMBODIMENTS) | 2019 |
|
RU2733080C1 |
| PHARMACOLOGICAL COMPOSITION FOR TREATING PROCTOLOGIC DISEASES (VERSIONS) | 2013 |
|
RU2592366C2 |
| AGENT FOR PYOINFLAMMATORY PROCESSES IN SOFT TISSUES AND MUCOUS MEMBRANES | 2017 |
|
RU2646462C1 |
| INJECTION DRUG FORM FOR TREATMENT AND PREVENTION OF LIVER DISEASES IN ANIMALS | 2012 |
|
RU2504347C1 |
| METHOD OF PREPARING WATER-SOLUBLE PHARMACEUTICAL COMPOSITION BASED ON BERBERINE | 2023 |
|
RU2814497C1 |
| METHOD OF PREPARING A PHARMACEUTICAL GEL COMPOSITION FOR TREATING PROCTOLOGIC DISEASES (VERSIONS) | 2020 |
|
RU2730483C1 |
| CYCLOPHERONE-BASED PHARMACEUTICAL COMPOSITION OF LOCAL OR EXTERNAL APPLICATION FOR TREATMENT OF PURULENT-DESTRUCTIVE AFFECTION OF MUCOUS MEMBRANE AND SKIN, GENERAL-SYSTEM DISEASES IN CASE OF IMMUNODEFICIENCY CONDITIONS (VERSIONS) | 2008 |
|
RU2414221C2 |
| COMPOSITION FOR TREATING BACTERIAL INFECTIONS IN ANIMALS | 2009 |
|
RU2397753C1 |
| TOPICAL AND EXTERNAL TILORONE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PURULENT-DESTRUCTIVE MUCOSAL AND SKIN DISEASES, SYSTEMIC DISEASES IN IMMUNODEFICIENCY STATES | 2008 |
|
RU2401104C2 |
